1. Home
  2. RVMDW vs LARK Comparison

RVMDW vs LARK Comparison

Compare RVMDW & LARK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMDW
  • LARK
  • Stock Information
  • Founded
  • RVMDW N/A
  • LARK 1885
  • Country
  • RVMDW United States
  • LARK United States
  • Employees
  • RVMDW 490
  • LARK N/A
  • Industry
  • RVMDW
  • LARK Major Banks
  • Sector
  • RVMDW
  • LARK Finance
  • Exchange
  • RVMDW Nasdaq
  • LARK Nasdaq
  • Market Cap
  • RVMDW N/A
  • LARK N/A
  • IPO Year
  • RVMDW N/A
  • LARK N/A
  • Fundamental
  • Price
  • RVMDW $0.38
  • LARK $22.79
  • Analyst Decision
  • RVMDW
  • LARK
  • Analyst Count
  • RVMDW 0
  • LARK 0
  • Target Price
  • RVMDW N/A
  • LARK N/A
  • AVG Volume (30 Days)
  • RVMDW N/A
  • LARK 1.3K
  • Earning Date
  • RVMDW N/A
  • LARK 10-30-2024
  • Dividend Yield
  • RVMDW N/A
  • LARK 3.48%
  • EPS Growth
  • RVMDW N/A
  • LARK 14.21
  • EPS
  • RVMDW N/A
  • LARK 2.25
  • Revenue
  • RVMDW N/A
  • LARK $56,988,000.00
  • Revenue This Year
  • RVMDW N/A
  • LARK N/A
  • Revenue Next Year
  • RVMDW N/A
  • LARK N/A
  • P/E Ratio
  • RVMDW N/A
  • LARK $10.22
  • Revenue Growth
  • RVMDW N/A
  • LARK N/A
  • 52 Week Low
  • RVMDW N/A
  • LARK $17.90
  • 52 Week High
  • RVMDW N/A
  • LARK $23.20
  • Technical
  • Relative Strength Index (RSI)
  • RVMDW N/A
  • LARK 66.66
  • Support Level
  • RVMDW N/A
  • LARK $21.79
  • Resistance Level
  • RVMDW N/A
  • LARK $23.20
  • Average True Range (ATR)
  • RVMDW 0.00
  • LARK 0.37
  • MACD
  • RVMDW 0.00
  • LARK 0.12
  • Stochastic Oscillator
  • RVMDW 0.00
  • LARK 84.70

About RVMDW Revolution Medicines Inc. Warrant

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

Share on Social Networks: